In India, prostate cancer is the second most common cancer among men after oral cancer, and its incidence has been rising steadily particularly in urban populations and men over 50. What makes it both challenging and, in many cases, very manageable is the same thing: it usually grows slowly, often without any symptoms in its early stages. Most men who are eventually diagnosed had no idea anything was wrong.
That silence is what makes awareness matter. Prostate cancer caught at Stage 1 or 2 has survival rates above 95%. Caught at Stage 4, after it has spread to the bones or distant organs, the picture changes substantially. The difference, in most cases, comes down to whether a man knew what to watch for and whether he went for screening when he should have.
What Is the Prostate Cancer ?
The prostate is a small, walnut-sized gland located just below the bladder in men. It surrounds the urethra, the tube that carries urine and semen out of the body. Its main function is to produce seminal fluid, which nourishes and transports sperm.
How Does Prostate Cancer Develop?
Prostate cancer develops when cells in the prostate grow uncontrollably. Most cases begin in the glandular cells of the prostate and are called adenocarcinomas. As the tumour grows, it may press on the urethra, causing urinary symptoms.
Not all prostate cancers behave the same way. Some grow very slowly and may only need regular monitoring, while others are aggressive and require immediate treatment. Doctors use the Gleason Score to determine how aggressive the cancer is and choose the most appropriate treatment plan.
Causes and Risk Factors of Prostate Cancer
The exact cause of prostate cancer is unknown, but several factors increase the risk.
Age is the biggest risk factor. Prostate cancer is uncommon before 50 years and becomes much more common after that, especially between 60 and 75 years.
A family history of prostate cancer also increases risk. Men with a father or brother diagnosed with the disease, or those with BRCA1 or BRCA2 gene mutations, are more likely to develop prostate cancer and may need earlier screening.
Lifestyle also plays a role. A diet high in red and processed meat, obesity, physical inactivity, and smoking have all been linked to a higher risk, particularly of aggressive prostate cancer.
Some ethnic groups, especially men of African descent, have a higher risk of developing prostate cancer and are more likely to have aggressive disease.
Having one or more risk factors does not mean you will develop prostate cancer. However, it does mean regular PSA screening, healthy lifestyle habits, and early medical consultation become even more important.
Early Warning Signs of Prostate Cancer
Early prostate cancer usually causes no symptoms, which is why regular screening is so important. Symptoms often appear only after the tumour grows or spreads.
Common warning signs include:
Difficulty urinating, such as a weak urine stream, trouble starting urination, or feeling that the bladder is not completely empty. These symptoms are also common in benign prostatic hyperplasia (BPH), so a medical evaluation is needed to find the exact cause.
Frequent urination, especially at night (nocturia), that is new or gradually worsening.
Blood in the urine or semen, which should always be checked by a doctor, especially in men over 50.
Persistent pain in the lower back, hips, or pelvis, which may occur if prostate cancer has spread to nearby bones.
Pain during ejaculation or sudden erectile dysfunction, although these symptoms can also have many non-cancerous causes.
These symptoms do not always mean prostate cancer, but if they persist or worsen, consult a urologist promptly. Early diagnosis offers the best chance of successful treatment.
Prostate Cancer Screening: Who Should Get Tested and When
Prostate cancer screening helps detect cancer before symptoms appear, when treatment is most effective.
PSA Blood Test
The Prostate-Specific Antigen (PSA) test measures a protein produced by the prostate. A high PSA level does not always mean cancer it can also be caused by benign prostate enlargement (BPH) or prostatitis. However, persistently high or rising PSA levels need further evaluation.
Men at average risk should discuss PSA screening with their doctor from 50 years of age. Those with a family history of prostate cancer or BRCA1/BRCA2 gene mutations should consider starting around 45 years.
Digital Rectal Examination (DRE)
During a Digital Rectal Examination (DRE), the doctor checks the prostate for changes in size, shape, or texture. It is usually performed along with the PSA test to improve screening accuracy.
It is important to remember that PSA and DRE are screening tests, not diagnostic tests. If either test is abnormal, your doctor may recommend further investigations such as an MRI scan or prostate biopsy to confirm the diagnosis.
How Prostate Cancer Is Diagnosed
When PSA levels are elevated or a DRE raises concern, the diagnostic pathway typically involves the following:
A prostate biopsy is the definitive way to confirm prostate cancer. A needle guided by transrectal ultrasound takes multiple small tissue samples from different parts of the prostate. These samples are examined under a microscope, and if cancer is present, the Gleason score is assigned based on how abnormal the cells look. A higher Gleason score indicates more aggressive cancer behaviour.
MRI of the prostate specifically multiparametric MRI (mpMRI) has become increasingly used before biopsy to identify areas of suspicion within the prostate and guide the biopsy needle more precisely. This reduces the number of unnecessary biopsies and improves detection of clinically significant cancers.
Bone scan, CT scan, and PET scan are used when there is concern that the cancer has spread beyond the prostate to nearby lymph nodes, bones, or distant organs. These imaging tests establish the stage of the disease and determine how extensive treatment needs to be.
Stages of Prostate Cancer
Stage 1
Prostate cancer is confined to the prostate, involves a small area, and has a low Gleason score. It is highly treatable, and in many cases, active surveillance rather than immediate treatment is appropriate.
Stage 2
Prostate cancer is still confined to the prostate but is larger or has a higher Gleason score, indicating more aggressive biology. Surgery or radiation therapy is typically recommended.
Stage 3
Prostate cancer has spread beyond the outer layer of the prostate to nearby tissues or seminal vesicles. Treatment typically combines radiation with hormone therapy.
Stage 4
Prostate cancer has spread to nearby lymph nodes, bones, or distant organs. Treatment at this stage focuses on controlling the disease and maintaining quality of life. Modern hormone therapies, chemotherapy, and targeted agents have extended survival meaningfully in Stage 4 disease over the past decade.
Treatment Options for Prostate Cancer
Treatment depends on the stage of cancer, PSA level, Gleason score, age, overall health, and personal preferences. Many men receive a combination of treatments.
Active Surveillance
Low-risk, slow-growing prostate cancer may not need immediate treatment. Instead, doctors monitor it with regular PSA tests, digital rectal exams (DRE), scans, and repeat biopsies. This helps avoid unnecessary side effects while ensuring the cancer is closely watched.
Surgery (Radical Prostatectomy)
Surgery removes the entire prostate gland and is commonly recommended for localized prostate cancer. Many hospitals now perform robotic-assisted surgery, which offers smaller cuts, less blood loss, and quicker recovery. When possible, nerve-sparing techniques help reduce the risk of urinary leakage and erectile dysfunction.
Radiation Therapy
Radiation is an effective alternative to surgery. External Beam Radiation Therapy (EBRT) directs high-energy rays at the prostate, while brachytherapy places radioactive seeds inside the gland. Both treatments aim to destroy cancer cells while preserving nearby healthy tissue.
Hormone Therapy (Androgen Deprivation Therapy)
Hormone therapy lowers male hormones (androgens) that help prostate cancer grow. It is often used for advanced or metastatic prostate cancer, alongside radiation therapy, or if cancer returns after treatment.
Chemotherapy
Chemotherapy is mainly used when prostate cancer has spread beyond the prostate or no longer responds to hormone therapy. It helps slow cancer growth, relieve symptoms, and improve survival.
Focal Therapies
Selected patients may benefit from minimally invasive treatments such as High-Intensity Focused Ultrasound (HIFU) or cryotherapy, which destroy only the cancerous part of the prostate while preserving as much healthy tissue as possible.
Your urologist or oncologist will recommend the most suitable treatment plan based on your cancer stage, overall health, and long-term goals.
Prostate Cancer Myths Cleared Up
Myth: Only older men get prostate cancer.
Risk increases with age, and most diagnoses occur after 60. But prostate cancer does occur in younger men — particularly those with a family history or inherited BRCA mutations. Age is a risk factor, not a guarantee, and it is not a reason for younger men with symptoms to delay evaluation.
Myth: A high PSA always means cancer.
PSA can be elevated for multiple reasons — BPH, prostatitis, recent sexual activity, or even vigorous cycling. An elevated PSA is a reason to investigate further, not a diagnosis. Conversely, some aggressive prostate cancers can occur with relatively normal PSA levels. PSA is a useful tool with real limitations — it works best as part of an ongoing monitoring conversation with a doctor, not as a single test interpreted in isolation.
Myth: Prostate cancer always causes symptoms.
Early prostate cancer almost never causes symptoms. This is the most important misconception to correct — it is precisely why screening exists, and why waiting for symptoms before getting tested means waiting until the cancer has already progressed.
Prevention Options for Prostate Cancer
No intervention eliminates prostate cancer risk entirely, but several lifestyle factors are associated with lower risk. A diet high in vegetables particularly cruciferous vegetables like broccoli and cauliflower and low in red and processed meat is consistently associated with lower prostate cancer rates across population studies. Maintaining a healthy weight, exercising regularly, and avoiding smoking all contribute to lower risk of aggressive prostate cancer specifically. Men with a family history of prostate or BRCA-related cancers should discuss genetic counselling and earlier screening timelines with their doctor.
When Should You See a Doctor?
If you are over 50 and haven’t discussed PSA screening with your doctor that conversation is overdue. If you have a family history of prostate cancer or known BRCA mutations, start that conversation at 45.
See a doctor promptly if you notice difficulty urinating, a weak or interrupted urine stream, blood in urine or semen, unexplained pelvic or lower back pain, or any rapid change in urinary patterns.
An online oncologist consultation through HealthPil is available for PSA result interpretation, second opinions on diagnosis, treatment planning guidance, and specialist advice from home.
How HealthPil Can Help
HealthPil connects men and their families with experienced urologists and oncologists for prostate cancer screening guidance, diagnosis support, treatment planning, and second opinions. Whether you have a concerning PSA result, have been recently diagnosed, or want to understand your screening options expert help is available online.
Book your online consultation with HealthPil today.
Summary
Prostate cancer is the second most common cancer in Indian men and is highly treatable when caught early with survival rates above 95% at Stage 1. Most early prostate cancers cause no symptoms, which is why PSA screening from age 50 is important. Warning signs that do appear include difficulty urinating, frequent nighttime urination, blood in urine or semen, and unexplained pelvic or bone pain. Diagnosis involves PSA testing, DRE, MRI, and prostate biopsy with Gleason scoring. Treatment options range from active surveillance for low-risk disease to robotic surgery, radiation therapy, hormone therapy, and chemotherapy depending on stage and cancer biology. Family history and BRCA mutations are important risk factors that warrant earlier screening conversations.
FAQs-
At what age should men in India start prostate cancer screening?
Men at average risk should discuss PSA screening with their doctor from age 50. Men with a family history of prostate cancer or known BRCA gene mutations should consider starting that conversation at 45.
Is prostate cancer curable?
Early-stage prostate cancer confined to the prostate is highly treatable with surgery or radiation therapy, with excellent long-term outcomes. Even advanced prostate cancer, while not curable, is increasingly manageable with modern hormone therapies and targeted agents.
What is the Gleason score?
The Gleason score is a grading system used to describe how aggressive a prostate cancer is, based on how abnormal the cancer cells look under a microscope. Higher scores indicate more aggressive cancer behaviour and typically require more intensive treatment.
Can prostate cancer be detected without symptoms?
Yes — and this is the entire purpose of PSA screening. Most early prostate cancers cause no symptoms at all. Regular PSA testing from the appropriate age allows detection before the cancer progresses.
Does prostate cancer affect sexual function?
The cancer itself may affect sexual function in advanced stages. More commonly, treatment particularly surgery and hormone therapy can affect erectile function and libido. Nerve-sparing surgical techniques and newer approaches have reduced this risk, and these are important conversations to have with the treating surgeon before deciding on treatment.
What is the survival rate for prostate cancer?
The survival rate of prostate cancer is great, especially when discovered early. For localised prostate cancer, the five-year survival rate is almost 100%.
References
- Mohler JL, et al. Prostate Cancer. StatPearls Publishing. Available at:
NCBI Bookshelf - Eastham JA, et al. Prostate Cancer: Diagnosis and Management. Available at:
PubMed
Disclaimer:
The content presented here is intended solely for educational purposes and should not be used in place of expert medical advice, diagnosis, or care. For medical advice unique to your condition, always seek the advice of your healthcare professional.
